Action grants to support actions to improve access to human papillomavirus vaccination
Summary
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Programme Name
Programme Description
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Call
Detailed Call Description
The action will support civil society organisations, including non-governmental organisations, to complement the Member States’ actions according to national and regional needs related to HPV vaccination policies and programmes. The activities which will be funded will include targeted meetings, workshops, and other initiatives to sharing information with national and regional authorities of Member States, which need to start large-scale HPV vaccination campaigns, with the main objective to receive support through the provision of expertise, best practices, and guidelines covering the planning and roll-out of vaccination campaigns.
These activities may include training (including training of trainers) on how to successfully communicate with parents and patients on HPV vaccination, how to ensure the provision of consistent messages to the public, and the provision of concrete examples on how to support vaccination in other Member States. Activities may include recommendations for the ‘bundling’ of all adolescent vaccines, including the HPV vaccine, by establishing a policy to check patients’ immunisation status at every visit and to always recommend and administer vaccines to those in need. Actions will be designed on the already available evidence-based understanding of behavioural determinants of vaccination acceptance for HPV vaccination.
Financing percentage by EU or other bodies / Level of Subsidy or Loan
60% Applicants can apply for a higher project funding rate (maximum 80%) if your project is of ‘exceptional utility’.
Eligibility For Participation Notes
In order to be eligible for funding, the applicants (beneficiaries and affiliated entities) must:
- be legal entities (public or private bodies) created under Union law or an international organisation, or
- be established in one of the eligible countries, i.e.:
- EU Member States (including overseas countries and territories linked to it (OCTs)
- eligible non-EU countries: EEA countries and countries associated to the EU4Health Programme (third countries, candidate countries and potential candidate countries, neighbourhood countries) or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before grant signature.
Programme Category
EU Competitive ProgrammesTotal Budget
€1,200,000Thematic Categories
- Health
Eligibility for Participation
- Central Government
- International Organisations
- NGOs
- Non Profit Organisations
- Private Bodies
- State-owned Enterprises
Call Opening Date
14/10/2021Call Closing Date
25/01/2022National Contact Point(s)
Ministry of Health, Department of European Affairs
Ms MAKRIGIORGI Elena
emakrigiorgi@moh.gov.cy
(Publish Date: 27/10/2021-for internal use only)
EU Contact Point
Stefan DE KEERSMAECKER
Telephone: +32 2 298 46 80
Email: stefan.de-keersmaecker@ec.europa.eu
Darragh CASSIDY
Telephone: +32 2 298 39 78
Email: darragh.cassidy@ec.europa.eu
